Skip to content

Evaluation of the perioperative circulatory stability and analgesic effect of S(+)-ketamine in general anesthesia

Evaluation of the perioperative circulatory stability and analgesic effect of S(+)-ketamine in general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039440
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-11-30
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver and gallbladder surgery

Interventions

control group:normal saline
experimental group:S(+)-ketamine

Sponsors

Tangshan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged between 18 and 60;Elective liver and gallbladder surgery ASA rating I ~ II level; Weight 45 ~ 85 kg; Height 150 ~ 185 cm;Anesthesia duration >= 2 hours; Intravenous controlled analgesia pump was used after operation.

Exclusion criteria

Exclusion criteria: 1. Those with incomplete clinical examination data and researchers think it is inappropriate to participate in this study. 2. Hypertensive patients whose blood pressure is not satisfactorily controlled by antihypertensive drugs; 3. Patients with water and electrolyte disturbances, severe atrioventricular block and severe cardiac insufficiency; 4. Pregnant or lactating women; 5. Patients with diseases of the blood system, respiratory system, digestive system and endocrine system caused by other diseases, as well as mental disorders and other diseases cannot cooperate with others; 5. Patients with drug intolerance or allergy are known in this study. 6. Those who have a history of sedative and hypnotic drug use and a history of long-term alcohol and drug abuse before operation; 7. Preoperative ecg indicated heart rate (HR)& LT; 8. 60 times /min or & GT;100 times /min; 9. Patients with peripheral vascular diseases, recent use of vasoactive drugs, antidepressants and painkillers; 10. Extreme mental stress, other accidents and the use of blood products during the operation; 11. Have a history of brain injury, intracranial hypertension, cerebral aneurysms, cerebrovascular accidents and central nervous system diseases.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure, heart rate, blood oxygen saturation, and BIS;VAS pain score;The dosage of analgesics;The propofol dosage of BIS under 60 cents;Ramsay sedation score;

Secondary

MeasureTime frame
Occurrence of intraoperative and postoperative adverse reactions;

Countries

China

Contacts

Public ContactYanrong Xu

Department of Anesthesiology, Tangshan Central Hospital

xyrfs@126.com+86 18532660166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026